The study examines whether shorter antibiotic treatment periods can be as effective as standard longer treatments. Patients will receive antibiotics through oral administration for different durations, with some patients taking the medication for a shorter time than others. The maximum treatment period will be 14 days.

During the study, patients will be monitored to see if their symptoms improve, particularly checking for the disappearance of fever and overall improvement in their condition. The study will track how quickly patients feel better and whether they need any additional treatment. Patients will keep a diary to record their symptoms and any side effects they experience during the treatment period.

The study involves giving participants injections of the vaccines and monitoring them for any reactions or side effects. Some participants will receive the actual vaccines, while others will receive a placebo, which is a substance with no active ingredients. The purpose of the study is to evaluate the safety and how the body responds to these vaccines, which are designed to help the immune system fight off infections.

Throughout the study, participants will be closely observed for any signs of illness or adverse reactions. The study aims to gather information on how the vaccines affect the immune system and whether they can help prevent serious respiratory infections in young children. This research is important for developing new ways to protect children from these infections and improve their overall health.

The purpose of the study is to see if giving these bacterial lysates to preterm infants can help reduce the number of respiratory infections and wheezing episodes they experience. The study will involve giving the medication to the infants and observing them over a period of time to see if it helps in reducing these health issues. Some infants will receive the actual medication, while others will receive a placebo, which looks like the medication but does not contain the active ingredients. This helps researchers understand the true effect of the medication.

Throughout the study, researchers will monitor the infants to see how many times they get sick with respiratory infections or wheeze, and how long it takes for these symptoms to appear. They will also look at other factors like the use of additional medications, the infants’ lung function, and their overall quality of life. The study aims to provide valuable information on whether this treatment can help improve the health of preterm infants by boosting their immune system early on.

The purpose of the study is to understand how acyclovir affects the health outcomes of these patients, specifically looking at survival rates over a 30-day period. Participants in the study will receive either acyclovir or a placebo, and their progress will be monitored over time. The study will also track other factors such as the number of days patients can breathe without the help of a machine, the length of their stay in the hospital, and their overall quality of life during and after the treatment.

Throughout the study, researchers will collect data to see if acyclovir helps reduce the presence of HSV-1 in the lungs and improves the patients’ recovery. The study aims to provide valuable insights into the potential benefits of using acyclovir for patients with pneumonia and HSV-1, ultimately helping to improve treatment strategies for these serious conditions.

Participants in the study will be children aged 6 weeks to 12 years who are hospitalized and require additional oxygen. The study will compare two different oxygen level targets to see which one is more effective in helping children recover faster. The trial will monitor various aspects of the children’s recovery, including the time it takes for them to meet all discharge criteria, the length of their hospital stay, and their overall health after leaving the hospital.

Throughout the study, researchers will also look at other factors such as the number of admissions to the pediatric intensive care unit (PICU), the time spent on oxygen therapy, and the duration of symptoms. Additionally, the study will consider the children’s quality of life, parental anxiety, and the economic impact of the treatment. The goal is to find a safe and effective way to manage oxygen levels in children with respiratory distress, ultimately improving their recovery and overall health.

The purpose of the study is to gather more information about how well Buccalin works in preventing these recurrent infections. Participants in the study will be randomly assigned to receive either Buccalin or the placebo. The study will last for 12 months, during which the number of infection episodes will be monitored and compared between the two groups. Additionally, the study will look at the duration of each infection, the number of antibiotic treatments needed, and the number of sick days experienced by participants.

Throughout the study, participants will be asked to fill out a simple scale to rate their health condition, ranging from 0 (the worst) to 10 (the best). The safety of Buccalin will also be evaluated by monitoring any side effects that occur. This study aims to provide valuable insights into the potential benefits of Buccalin for individuals who frequently experience lower respiratory tract infections.